Retatrutide | 6mg
GU-P006
11200,00
грн.
Retatrutide is an experimental drug under development for the treatment of obesity and related metabolic disorders, such as type 2 diabetes. It acts as an agonist of multiple hormonal receptors that regulate appetite and metabolism in the body. The primary goal of Retatrutide is to aid in weight loss by reducing appetite, increasing feelings of fullness, and regulating glucose metabolism.
The mechanism of action of Retatrutide involves interaction with three hormones: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and glucagon. These hormones play a key role in controlling appetite, insulin secretion, and fat breakdown.
This drug is part of a new generation of weight-loss medications being developed to provide more effective and lasting solutions for managing body weight and metabolic diseases.
This peptide offers a range of benefits, particularly in the context of weight loss and managing metabolic disorders such as type 2 diabetes. Here are the main benefits of its use:
Significant Weight Loss: Retatrutide is targeted at individuals with obesity or overweight. Clinical trials have shown that it leads to significant and sustained weight loss by reducing appetite and increasing satiety. In some studies, users have lost up to 24% of their body weight after prolonged treatment.
Improved Blood Glucose Control: Retatrutide regulates glucose metabolism, making it especially beneficial for patients with type 2 diabetes. As a GLP-1 receptor agonist, it enhances insulin secretion and improves blood glucose control, reducing post-meal glucose levels.
Regulation of Appetite and Metabolism Hormones: The drug’s mechanism of action involves activating three hormones: GLP-1, GIP, and glucagon. This helps with better appetite control and fat burning, leading to more effective weight loss.
Reduced Cardiovascular Risk: By promoting weight loss and improving metabolic profiles (blood glucose, cholesterol), Retatrutide can reduce the risk of cardiovascular diseases, which are often linked to obesity and diabetes.
Improved Lipid Profile: The medication may also help lower levels of "bad" LDL cholesterol and triglycerides, further enhancing overall health.
Potential to Treat Liver Diseases (NAFLD/NASH): Retatrutide is also being investigated for its potential benefits in treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are associated with metabolic disorders.
Proper Dosage and Administration of Retatrutide :
Retatrutide Dosage:
The dosage of Retatrutide depends on individual needs and the patient’s condition, making prior consultation with a healthcare provider essential to determine the correct dosage and administration method.
Administration Method :
Retatrutide is administered via subcutaneous injection once per week.The initial dosage is typically 2mg, which may be increased to 6mg or 8mg, depending on the patient’s requirements.If a dose is missed, it should be administered as soon as possible, but a double dose should not be given.
Additional Usage Instructions :
1 unit corresponds to 1 division on the dosage dial (or the number displayed when turning the dial).Inject into the abdominal area or the front of the thigh.After injecting, wait 10 seconds before removing the needle.It is recommended to rotate the injection site to avoid irritation.
Pen Information:
Retatrutide 6mg Pen: Contains 120 units of 50μg. Unit-to-Milligram Conversion:
Retatrutide, like many other medications, may cause side effects, although not all patients will experience them. The most common adverse reactions are related to the digestive system, as the medication affects hormones that regulate appetite and metabolism. It is important to note that higher doses may lead to more pronounced side effects.
Nausea: One of the most commonly reported side effects of Retatrutide. Nausea is usually mild to moderate but can be more intense at higher doses. It generally decreases over time as the body adapts to the medication.
Vomiting: Some patients report vomiting, especially at the beginning of treatment or with a rapid increase in dosage.
Diarrhea or Constipation: Changes in the digestive system, including diarrhea or constipation, are also common among patients taking Retatrutide. These issues are often temporary, but dose adjustments may be required for some individuals.
Fatigue: A feeling of fatigue or weakness may occur, particularly during the early stages of treatment.
Increased Heart Rate: Some patients may experience a slight increase in pulse during physical activity.
Most side effects of Retatrutide are reversible and easily manageable. However, patients should be monitored by a healthcare provider during treatment to ensure the therapy's safety and effectiveness.
The mechanism of action of Retatrutide involves interaction with three hormones: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic peptide), and glucagon. These hormones play a key role in controlling appetite, insulin secretion, and fat breakdown.
This drug is part of a new generation of weight-loss medications being developed to provide more effective and lasting solutions for managing body weight and metabolic diseases.
This peptide offers a range of benefits, particularly in the context of weight loss and managing metabolic disorders such as type 2 diabetes. Here are the main benefits of its use:
Significant Weight Loss: Retatrutide is targeted at individuals with obesity or overweight. Clinical trials have shown that it leads to significant and sustained weight loss by reducing appetite and increasing satiety. In some studies, users have lost up to 24% of their body weight after prolonged treatment.
Improved Blood Glucose Control: Retatrutide regulates glucose metabolism, making it especially beneficial for patients with type 2 diabetes. As a GLP-1 receptor agonist, it enhances insulin secretion and improves blood glucose control, reducing post-meal glucose levels.
Regulation of Appetite and Metabolism Hormones: The drug’s mechanism of action involves activating three hormones: GLP-1, GIP, and glucagon. This helps with better appetite control and fat burning, leading to more effective weight loss.
Reduced Cardiovascular Risk: By promoting weight loss and improving metabolic profiles (blood glucose, cholesterol), Retatrutide can reduce the risk of cardiovascular diseases, which are often linked to obesity and diabetes.
Improved Lipid Profile: The medication may also help lower levels of "bad" LDL cholesterol and triglycerides, further enhancing overall health.
Potential to Treat Liver Diseases (NAFLD/NASH): Retatrutide is also being investigated for its potential benefits in treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are associated with metabolic disorders.
Proper Dosage and Administration of Retatrutide :
Retatrutide Dosage:
The dosage of Retatrutide depends on individual needs and the patient’s condition, making prior consultation with a healthcare provider essential to determine the correct dosage and administration method.
Administration Method :
Retatrutide is administered via subcutaneous injection once per week.The initial dosage is typically 2mg, which may be increased to 6mg or 8mg, depending on the patient’s requirements.If a dose is missed, it should be administered as soon as possible, but a double dose should not be given.
Additional Usage Instructions :
1 unit corresponds to 1 division on the dosage dial (or the number displayed when turning the dial).Inject into the abdominal area or the front of the thigh.After injecting, wait 10 seconds before removing the needle.It is recommended to rotate the injection site to avoid irritation.
Pen Information:
Retatrutide 6mg Pen: Contains 120 units of 50μg. Unit-to-Milligram Conversion:
- 1 unit = 50μg
- 10 units = 0.50mg
- 20 units = 1mg
- 30 units = 1.5mg
- 40 units = 2mg
- 1 unit = 100μg
- 10 units = 1mg
- 20 units = 2mg
- 25 units = 2.5mg
- 40 units = 4mg
- 60 units = 6mg
Retatrutide, like many other medications, may cause side effects, although not all patients will experience them. The most common adverse reactions are related to the digestive system, as the medication affects hormones that regulate appetite and metabolism. It is important to note that higher doses may lead to more pronounced side effects.
Nausea: One of the most commonly reported side effects of Retatrutide. Nausea is usually mild to moderate but can be more intense at higher doses. It generally decreases over time as the body adapts to the medication.
Vomiting: Some patients report vomiting, especially at the beginning of treatment or with a rapid increase in dosage.
Diarrhea or Constipation: Changes in the digestive system, including diarrhea or constipation, are also common among patients taking Retatrutide. These issues are often temporary, but dose adjustments may be required for some individuals.
Fatigue: A feeling of fatigue or weakness may occur, particularly during the early stages of treatment.
Increased Heart Rate: Some patients may experience a slight increase in pulse during physical activity.
Most side effects of Retatrutide are reversible and easily manageable. However, patients should be monitored by a healthcare provider during treatment to ensure the therapy's safety and effectiveness.
© Усі права захищені та належать Gluta-Beauty
Інформація
- Доставка і оплата
- Політика конфіденційності
Контакти
- Інстаграм
- Вайбер
Політика конфідійності
Текст....